Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Jun;20(6):1218-22.
doi: 10.1038/oby.2011.216. Epub 2011 Jul 14.

Relationship between treatment preference and weight loss in the context of a randomized controlled trial

Affiliations
Randomized Controlled Trial

Relationship between treatment preference and weight loss in the context of a randomized controlled trial

Kelley E Borradaile et al. Obesity (Silver Spring). 2012 Jun.

Abstract

Randomized controlled trials (RCTs) are considered the gold standard used to assess the efficacy of treatment. While a well implemented RCT can produce an unbiased estimate of the relative difference between treatment groups, the generalizability of these findings may be limited. Specific threats to the external validity include treatment preference. The purposes of this study were to: (i) assess whether receiving one's treatment preference was associated with weight loss and retention and (ii) whether receiving one's treatment preference modified the relationship between the treatments and weight loss. Treatment preference was assessed in 250 subjects prior to but independent of randomization into either low-carbohydrate or low-fat diets. Treatment preference was a predictor of weight loss (P = 0.002) but not retention (P = 0.90). Participants who received their preference lost less weight (-7.7 kg, 95% confidence interval (CI): -9.3 to -6.1) than participants who did not receive their preference (-9.7 kg, 95% CI: -11.4 to -8.1) and participants who did not report a strong preference at baseline (-11.2 kg, 95% CI: -12.6 to -9.7) (P = 0.04 and P = 0.0004, respectively). Treatment preference did not modify the effect of the treatment on weight loss. Contrary to conceptual predictions, this study failed to identify an interaction between treatment preference and weight loss in the setting of a randomized trial. Until treatment preference effects are definitively ruled out in this domain, future studies might consider stratifying their randomization procedure by treatment preference rather than excluding participants with strong treatment preferences.

Trial registration: ClinicalTrials.gov NCT00143936.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The trichotomy of revalenced diet preference scores.
Figure 2
Figure 2
Change in weight (kg) by treatment preference group (those who received their preference, preference congruent, those who did report a strong preference, and those who did not receive their preference, preference incongruent). Data are from a repeated measures mixed effects model that included fixed effects for time, treatment (i.e., low-carbohydrate and low-fat), a time × treatment interaction, baseline weight, preference category (i.e., received preference, did not report a strong preference, and did not receive preference), and research site. A random effect was included for participant cohort. Over the course of the 24 month study, the preference congruent group lost less weight than the preference incongruent group (P = 0.04), and the group that did not report a strong preference (P = 0.0004). There was no difference in mean weight loss between the group that did not report a strong preference and the preference incongruent group (P = 0.14). The effect of preference on weight loss persisted across the 24 month study (the preference × time interaction was not statistically significant).

References

    1. Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet. 2005;365:82–93. - PubMed
    1. Epstein LH. Role of behavior theory in behavioral medicine. J Consult Clin Psychol. 1992;60:493–498. - PubMed
    1. Halpern SD. Evaluating preference effects in partially unblinded, randomized clinical trials. J Clin Epidemiol. 2003;56:109–115. - PubMed
    1. Murray DC. Preferred versus nonpreferred treatment and self-control training versus determination raising as treatments of obesity: a pilot study. Psychol Rep. 1976;38:191–198. - PubMed
    1. Renjilian DA, Perri MG, Nezu AM, et al. Individual versus group therapy for obesity: effects of matching participants to their treatment preferences. J Consult Clin Psychol. 2001;69:717–721. - PubMed

Publication types

Associated data